Neurotensin may function as a regulatory peptide in small cell lung cancer

Thomas P Davis, Susan Crowell, Brena McInturff, Renee Louis, Terry Gillespie

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Neurotensin (NT) has been postulated to act as a modulatory agent in the central nervous system. Besides its presence in mammalian brain, NT is produced by small cell carcinoma of the lung (SCLC) and cell lines derived from these tumors. Receptors have also been characterized in some SCLC cell lines leading to the suggestion that NT could regulate the growth of SCLC in an autocrine fashion similar to bombesin/GRP. Previously, we had reported that a 10 nM dose of NT and NT(8-13), but not NT(1-8), elevated cytosolic Ca2+, indicating that SCLC NT receptors may use Ca2+ as a second messenger. Using intact SCLC cells we report that time-course incubations with NT lead to the formation of the amino-terminal fragment NT(1-8) and small amounts of the C-terminal fragment NT(9-13). These fragments are formed by metalloendopeptidase 3.4.24.15 cleaving enzyme at the Arg8-Arg9 bond of NT. Significant levels of soluble 3.4.24.15 (10-17 nmoles/mg Pr-/min) are present in SCLC cell lines. Using the in vitro clonogenic assay we tested the effect of 0.5, 5.0 and 10.0 nM doses of NT, NT(1-8) and NT(8-13) on SCLC clonal growth. NT and the C-terminal fragment NT(8-13) stimulated colony formation whereas the N-terminal fragment did not. In summary, NT may function as a regulatory peptide in SCLC through the formation of peptide fragments.

Original languageEnglish (US)
Pages (from-to)17-23
Number of pages7
JournalPeptides
Volume12
Issue number1
DOIs
StatePublished - 1991

Fingerprint

Neurotensin
Small Cell Lung Carcinoma
neurotensin (8-13)
Cells
Peptides
Metalloendopeptidases
Neurotensin Receptors
Central Nervous System Agents
Cell Line
Bombesin
Peptide Fragments
Neurology
Second Messenger Systems
Growth
Tumor Cell Line
Tumors
Assays
Brain

Keywords

  • Clonogenic assay
  • Metalloendopeptidase 3.4.24.15
  • Neurotensin
  • Neurotensin fragments
  • Neutral endopeptidase 3.4.24.11
  • Peptide processing
  • Small cell lung cancer

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Neurotensin may function as a regulatory peptide in small cell lung cancer. / Davis, Thomas P; Crowell, Susan; McInturff, Brena; Louis, Renee; Gillespie, Terry.

In: Peptides, Vol. 12, No. 1, 1991, p. 17-23.

Research output: Contribution to journalArticle

Davis, TP, Crowell, S, McInturff, B, Louis, R & Gillespie, T 1991, 'Neurotensin may function as a regulatory peptide in small cell lung cancer', Peptides, vol. 12, no. 1, pp. 17-23. https://doi.org/10.1016/0196-9781(91)90160-Q
Davis, Thomas P ; Crowell, Susan ; McInturff, Brena ; Louis, Renee ; Gillespie, Terry. / Neurotensin may function as a regulatory peptide in small cell lung cancer. In: Peptides. 1991 ; Vol. 12, No. 1. pp. 17-23.
@article{e75b6501d7bb4e9cbac4fbfbfe9f4096,
title = "Neurotensin may function as a regulatory peptide in small cell lung cancer",
abstract = "Neurotensin (NT) has been postulated to act as a modulatory agent in the central nervous system. Besides its presence in mammalian brain, NT is produced by small cell carcinoma of the lung (SCLC) and cell lines derived from these tumors. Receptors have also been characterized in some SCLC cell lines leading to the suggestion that NT could regulate the growth of SCLC in an autocrine fashion similar to bombesin/GRP. Previously, we had reported that a 10 nM dose of NT and NT(8-13), but not NT(1-8), elevated cytosolic Ca2+, indicating that SCLC NT receptors may use Ca2+ as a second messenger. Using intact SCLC cells we report that time-course incubations with NT lead to the formation of the amino-terminal fragment NT(1-8) and small amounts of the C-terminal fragment NT(9-13). These fragments are formed by metalloendopeptidase 3.4.24.15 cleaving enzyme at the Arg8-Arg9 bond of NT. Significant levels of soluble 3.4.24.15 (10-17 nmoles/mg Pr-/min) are present in SCLC cell lines. Using the in vitro clonogenic assay we tested the effect of 0.5, 5.0 and 10.0 nM doses of NT, NT(1-8) and NT(8-13) on SCLC clonal growth. NT and the C-terminal fragment NT(8-13) stimulated colony formation whereas the N-terminal fragment did not. In summary, NT may function as a regulatory peptide in SCLC through the formation of peptide fragments.",
keywords = "Clonogenic assay, Metalloendopeptidase 3.4.24.15, Neurotensin, Neurotensin fragments, Neutral endopeptidase 3.4.24.11, Peptide processing, Small cell lung cancer",
author = "Davis, {Thomas P} and Susan Crowell and Brena McInturff and Renee Louis and Terry Gillespie",
year = "1991",
doi = "10.1016/0196-9781(91)90160-Q",
language = "English (US)",
volume = "12",
pages = "17--23",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Neurotensin may function as a regulatory peptide in small cell lung cancer

AU - Davis, Thomas P

AU - Crowell, Susan

AU - McInturff, Brena

AU - Louis, Renee

AU - Gillespie, Terry

PY - 1991

Y1 - 1991

N2 - Neurotensin (NT) has been postulated to act as a modulatory agent in the central nervous system. Besides its presence in mammalian brain, NT is produced by small cell carcinoma of the lung (SCLC) and cell lines derived from these tumors. Receptors have also been characterized in some SCLC cell lines leading to the suggestion that NT could regulate the growth of SCLC in an autocrine fashion similar to bombesin/GRP. Previously, we had reported that a 10 nM dose of NT and NT(8-13), but not NT(1-8), elevated cytosolic Ca2+, indicating that SCLC NT receptors may use Ca2+ as a second messenger. Using intact SCLC cells we report that time-course incubations with NT lead to the formation of the amino-terminal fragment NT(1-8) and small amounts of the C-terminal fragment NT(9-13). These fragments are formed by metalloendopeptidase 3.4.24.15 cleaving enzyme at the Arg8-Arg9 bond of NT. Significant levels of soluble 3.4.24.15 (10-17 nmoles/mg Pr-/min) are present in SCLC cell lines. Using the in vitro clonogenic assay we tested the effect of 0.5, 5.0 and 10.0 nM doses of NT, NT(1-8) and NT(8-13) on SCLC clonal growth. NT and the C-terminal fragment NT(8-13) stimulated colony formation whereas the N-terminal fragment did not. In summary, NT may function as a regulatory peptide in SCLC through the formation of peptide fragments.

AB - Neurotensin (NT) has been postulated to act as a modulatory agent in the central nervous system. Besides its presence in mammalian brain, NT is produced by small cell carcinoma of the lung (SCLC) and cell lines derived from these tumors. Receptors have also been characterized in some SCLC cell lines leading to the suggestion that NT could regulate the growth of SCLC in an autocrine fashion similar to bombesin/GRP. Previously, we had reported that a 10 nM dose of NT and NT(8-13), but not NT(1-8), elevated cytosolic Ca2+, indicating that SCLC NT receptors may use Ca2+ as a second messenger. Using intact SCLC cells we report that time-course incubations with NT lead to the formation of the amino-terminal fragment NT(1-8) and small amounts of the C-terminal fragment NT(9-13). These fragments are formed by metalloendopeptidase 3.4.24.15 cleaving enzyme at the Arg8-Arg9 bond of NT. Significant levels of soluble 3.4.24.15 (10-17 nmoles/mg Pr-/min) are present in SCLC cell lines. Using the in vitro clonogenic assay we tested the effect of 0.5, 5.0 and 10.0 nM doses of NT, NT(1-8) and NT(8-13) on SCLC clonal growth. NT and the C-terminal fragment NT(8-13) stimulated colony formation whereas the N-terminal fragment did not. In summary, NT may function as a regulatory peptide in SCLC through the formation of peptide fragments.

KW - Clonogenic assay

KW - Metalloendopeptidase 3.4.24.15

KW - Neurotensin

KW - Neurotensin fragments

KW - Neutral endopeptidase 3.4.24.11

KW - Peptide processing

KW - Small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=0026099869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026099869&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(91)90160-Q

DO - 10.1016/0196-9781(91)90160-Q

M3 - Article

VL - 12

SP - 17

EP - 23

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 1

ER -